Basic hellx-loop-hellx (bHLH) regulatory proteins are known to bind to a single DNA consensus sequence referred to as an E-box. The E-box is present in the regulatory elements of many developmentally controlled genes, including most muscle-specific genes such as troponin I (Tnl). Although the E-box consensus Is minimally defined as CANNTG, the adjacent nucleotides of functional E-boxes are variable for genes regulated by the bHLH proteins. In order to examine how E-box regulatory regions containing different internal and flanking nucleotides function when placed within the context of a single regulatory element, the E-box region (14 bp) present within the Tnl enhancer was substituted with the corresponding E-box sequences derived from the musde-specrfJc M-creatine kinase (MCK) and cardiac a-actin regulatory elements as well as from the immunoglobulin x (Ig*) enhancer. Within the Tnl enhancer, the E-box sequence derived from cardiac a-actln was Inactive whereas the corresponding sequence from the MCK right E-box efficiently restored wild-type enhancer activity in muscle cells. Intermediate levels of gene activity were observed for Tnl enhancers containing E-boxes derived from the MCK left E-box site or from the lgxE2 E-box. DNA binding studies of MyoD:E12 protein complexes with each substituted Tnl enhancer confirmed that DNA binding activity In vitro mimics the relative strength of the enhancers In vivo. These studies demonstrate that the specific nucleotide composition of individual Eboxes, which are contained within the regulatory elements of most if not all muscle-specific genes, contributes to the complex regulatory mechanisms governing bHLH-medlated gene expression.
INTRODUCTION
Recently, a family of transcription factors has been defined based on a conserved motif known as the basic helix-loop-helix (bHLH) domain. The bHLH domain consists of -60 amino acids and is responsible for the DNA binding and specific proteinrprotein interactions which characterize this protein family. The most widely studied members of the bHLH family are the four mammalian muscle regulatory factors, MyoD (1), myogenin (2, 3) , Myf-5 (4), and MRF4 (5, 6, 7) . Each muscle regulatory factor, when over-expressed in fibroblasts, converts cells to a muscle lineage. Fibroblasts expressing the muscle regulatory factors differentiate into myofibers and transcriptionally activate the contractile protein gene set in response to low concentrations of peptide growth factors. Muscle-specific gene expression induced by MyoD, myogenin, Myf-5, or MRF4 is mediated via binding of the proteins to specific DNA consensus sequences referred to as E-boxes, which are contained within the regulatory elements of most contractile protein genes (8) (9) (10) (11) .
Many bHLH proteins, including the four muscle regulatory factors, bind with similar nucleotide contacts to E-box sequences in vitro (12) (13) (14) (15) . High affinity binding occurs, however, when the muscle regulatory factors form hetero-dimers with the more widely expressed E2A bHLH proteins E12 and E47 (16, 17) . The E-box sequence, defined by the nucleotides CANNTG, is contained not only in the regulatory regions of most contractile protein genes but also in other genes regulated by bHLH proteins, including the B-cell specific immunoglobulin genes (18) . The Eboxes within muscle-specific regulatory elements are crucial for the correct developmental timing of expression since specific mutations within these sites eliminate muscle-specific gene activation (14, (19) (20) (21) (22) (23) .
Although the muscle regulatory factors bind to the CANNTG consensus sequence found within contractile protein genes, the nucleotides surrounding and internal to the consensus sequence are widely diverged. For example, of the approximately twenty characterized E-boxes from muscle-specific genes, including troponin I (Tnl) (14) , M-creatine kinase (MCK) (19) , cardiac a-actin (23) , myosin light chain (MLQ 1/3 (20, 24) , desmin (25) , and the acetylcholine receptor subunit genes (21, 22, 26, 27) , no two sequences are identical within a ten nucleotide region encompassing the E-box consensus. In addition, aside from the invariant CA and TG nucleotides, neither the internal nucleotides nor the flanking nucleotides are conserved, although the internal nucleotides of most muscle-specific E-boxes consist of two G/C base pairs.
Techniques developed to assess in vitro binding of muscle regulatory factors to randomly generated oligonucleotides have been utilized recently in an effort to determine the preferred sequences to which bHLH proteins bind. Wright et al. (28) used the cyclic amplification and selection of targets (CASTing) technique to characterize a high affinity binding site consensus for myogenin-containing complexes immunoprecipitated from muscle cell nuclear extracts. Although it is clear that myogenin preferentially associates with the identified consensus sequence, TTGCACCTGTTNNTT, this sequence is not present in any of the E-box regions known to be involved in the regulation of muscle-specific gene expression. Similar techniques also were employed to determine the optimal binding sequence of the MyoD:E12 protein complex (29) . Like the myogenin consensus site, this limited consensus, NXCACCTGTT/C (X = A, C, or G), is present in only one of eighteen known functional E-boxes (acetylcholine receptor 5-subunit) (26) . Thus, the sequences with the highest binding affinities in vitro may not reflect the optimal sequences necessary for contractile protein gene activation.
Among the genes that are regulated by E-box containing elements is the muscle-specific gene troponin I (14) . Developmental expression of the Tnl gene is dependent on an internal regulatory element (IRE), a 148 bp muscle-specific enhancer located within the first intron (30) . Three regions of the IRE are necessary for muscle-specific enhancer activity (14) . These sequences include an E-box that interacts with heterodimers of E12 and the muscle regulatory factors plus two additional sites, Site I and Site n, that bind ubiquitously expressed proteins essential to Tnl gene activity. Mutation of any one of (14) , the cardiac a-actin promoter (23) , the M-creatine kinase (MCK) enhancer (19) , and the immunoglobulin x enhancer (44) are shown. Open letters represent identica] nucleotides that are present within the troponin I E-box whereas solid letters indicate mismatches. The consensus sequence represents the MEF-1 consensus described by Buskin and Hauschka (38) . Scores were determined by assigning the value of 1.0 to the consensus nudeotkles (underlined) and a value of 0.5 to the degenerate nonconsensus nucleotides for a maximal possible score of 8.0.
the three binding sites results in > 85 % reduction in Tnl enhancer activity, suggesting that multiple protein interactions are required to achieve the proper expression of the Tnl gene.
In an effort to determine the dependence of Tnl enhancer activity on specific E-box nucleotides, we set out to substitute the E-box sequence of the Tnl IRE with different E-box sequences known to be important for the regulation of a number of other genes. Thus, the fourteen nucleotides encompassing the E-box consensus of troponin I were substituted with the corresponding nucleotides from the MCK right and left MyoD binding sites, the cardiac a-actin E-box, and the immunoglobulin xE2 E-box (19, 23, 31) . By comparing the activation of the same regulatory element containing different E-boxes, variability due to interactions with other transcription factors was eliminated. Cotransfection of these mutants with a MyoD expression vector produced different levels of taJ/is-activation in 10T1/2 cells, suggesting that the E-box sequence determines the extent to which a regulatory element is activated by muscle regulatory factors. Binding studies conducted in vitro also revealed that the affinity of the MyoD:E12 protein complex for each E-box element corresponds to the extent of fra/u-activation in vivo. Our studies suggest that the E-box sequence, excluding the binding consensus nucleotides, influences how the muscle regulatory factors interact with a regulatory element. Ultimately, specific interactions of the muscle regulatory factors with a targeted DNA sequence and with additional proteins bound to adjacent regulatory sites must function in concert to produce the appropriate expression pattern for each gene.
MATERIALS AND METHODS

Experimental gene constructions
Test plasmids were constructed using standard molecular techniques (32) and verified directly by dideoxy sequencing of double stranded plasmids (33) . Each E-box containing regulatory element was inserted 5' to the basal promoter element of Elb TATA-CAT in a 3' -5' orientation (34) . The Tnl IRE and Tnl mutant IRE were inserted into the Hind HI site of Elb TATA-CAT as described previously (14) . ActinElb was generated by adding Hind HI linkers to the (minus)CArG fragment (-100 to +68) isolated from the human cardiac a-actin reporter gene pHCAlOOCAT (35, 36) prior to cloning into Elb TATA-CAT. The MCK enhancer and mutant MCK enhancer were excised by Hind m digestion from pAEA (37) and from p(B3)AEA (38) , respectively, and then inserted into Elb TATA-CAT to generate MCKElb and mutMCKElb. Sequences containing the mouse immunoglobulin x enhancer (39) were amplified using the polymerase chain reaction (PCR) as described below from 1 /tg mouse genomic DNA in a reaction volume of 100 y\. Oligonucleotide primers complementary to +185 to +199 and +422 to +435 of the mouse Igx enhancer (39) were used for the PCR reaction. After addition of Hind m linkers to die Igx enhancer (+185 to +435), the corresponding fragment was cloned into the Hind m site of Elb TATA-CAT to generate IgxElb.
E-box substitutions were produced using the wild-type Tnl IRE inserted into die Hind III site of pBluescript KS+ (14) . Specific substitutions were introduced into the E-box region ( + 650 to +663) of the IRE using PCR mutagenesis. Briefly, oligonucleotides containing the desired E-box substitutions within die Tnl sequence +642 to +671, as well as an oligonucleotide complementary to die multiple cloning site of pBluescript KS + (Stratagene) were hybridized to the pBS-IRE plasmid and subjected to 30 cycles of PCR. PCR reactions contained 1 ng template DNA, 1 /tM of each primer, 200 /tM dNTP, 10 raM Tris-Cl (pH 8.3), 50 mM KC1, 1.5 mM MgCl 2 , 0.001% gelatin, and 5 units Taq DNA polymerase (Promega). Each cycle consisted of 1 min at 94°C, 1 min at 40°C, and 1 min at 72°C. Hind HI linkers were added to the amplified fragment, which then was digested with Hind IU and inserted into the Hind HI site of Elb TATA-CAT in a 5'-3' orientation. The oligonucleotides used in these studies consisted of the following sequences contained within the central region of a 30 nucleotide sequence representing Tnl +642 to +671 (the core E-box sequence is underlined while lower case letters represent changes in the wild-type DNA sequence): wild type Tnl, GAGACAGC TGCAGC; a-actin, GctcCAaCTQaccC; MCKR, ccaACAcCTGCtGC; MCKL, cAGACAtgTGgctg; Igx cAGgCAGgTGgccC.
Cell culture
C3H10T1/2 (10T1/2) fibroblasts were obtained from the American Type Culture Collection and maintained in growth medium containing BME (Basal Medium Eagle, Gibco) supplemented with 10% fetal bovine serum plus penicillin (100 units/ml) and streptomycin (100 /tg/ml). The myogenic cell line 23A2 was derived from 5-azacytidine treated 10T1/2 cells as described by Konieczny and Emerson (40) . 23 A2 myoblasts were maintained in growth medium (BME supplemented with 15% fetal bovine serum) or induced to differentiate by the addition of the defined medium ITS, which consists of low glucose DMEM, 5 /tg/ml insulin, 5 /ig/ml transferrin, 5 ng/ml selenium, and penicillin/streptomycin (30) .
Cell transfections and CAT assays
Transient DNA transfections were performed as described previously (30, 35) . For franj-activation studies, DNA precipitates containing 5 /tg of a CAT reporter gene and 5 /tg of the MyoD expression vector pEMCl Is or 5 /tg of the control pEMSVscribea2 vector (1) were added to 1X10 6 10T1/2 cells per 100mm dish. Five hours after the addition of DNA, cultures were subjected to an osmotic shock for 2 minutes in serum-free medium containing 20% glycerol and then incubated in normal growth medium. Differentiation medium was added to the cultures 24 hr after transfection. Protein extracts derived from transfected cultures were isolated by standard procedures 48 hours later as described previously (30) . Chloramphenicol acetyltransferase (CAT) assays were carried out as described by Gorman etal. (41) . For /rans-activation experiments, the amount of cell extract used in each CAT assay was normalized on the basis of protein concentration, which was determined by a modified Bradford assay (Bio-Rad) (42) . In most cases, 25 /tg of protein was used for each assay.
23A2 myofibers were transfected by the addition of DNA precipitates containing 5 /tg of a test CAT reporter gene and 5 /tg of the reference plasmid, pRSVLacZ (37) to lxlO 6 myoblasts per 100 mm dish. An osmotic shock was performed as described above, after which the cells were maintained in differentiation medium (ITS) for 48 hr. Myofiber protein extracts were assayed for /3-galactosidase activity as described previously (30, 43) . The amount of protein extract used for each CAT assay was normalized to the specific activity of the co-transfected (3-galactosidase gene product for each transfection group.
In vitro transcription and translation
MyoD and E12 RNA was synthesized in vitro using T3 RNA polymerase and a Maxiscript T7/T3 RNA polymerase in vitro transcription kit (Ambion) as per manufacturer's specifications. Transcription reactions included 1 /tg linearized pEMClls (MyoD) (1) or 1 /tg linearized pE12R (E12) (18) DNA, and P'-5 1 -(7-methyl)-guanosine-P^-5'-guanosine triphosphate (m7GpppG) capping solution (Boehringer). After incubation at 37°C for 30 minutes, the reactions were treated with DNase I for an additional 10 minutes. RNA then was extracted with phenol/chloroform and precipitated in ethanol using 1 /ig yeast tRNA as a carrier. A rabbit reticulocyte lysate system (Promega) was used for in vitro co-translation of newly synthesized E12 and MyoD RNA. Translation reactions containing ~ 1 /tg of MyoD and ~ 1 /tg of E12 RNA were incubated at 30°C for one hour in a total volume of 50 /tl. Aliquots of the reactions were stored at -80°C.
Gel mobility shift assays
To generate 32 P-labelled DNA probes, each IRE mutant was excised from the Elb TATA-CAT vectors using Hind IE, treated with alkaline phosphatase (Boehringer), and gel purified. Approximately 50 ng of each purified DNA fragment was labelled by filling-out Hind HI digested ends using the Klenow fragment of DNA polymerase I (New England Biolabs) and high specific activity (6000 Ci/mMol) [a-^P] ATP and [a-3
2 P] CTP (Amersham). Unincorporated nucleotides were removed after passage through a G-50 (Pharmacia) spin column.
For protein: DNA binding assays, end-labelled DNA probes (-10,000 cpm) were incubated with 0.5 /tg poly (dl-dQ and 5 /d of in vitro translated protein products at room temperature for 20 min. Binding reactions also contained 25 mM HEPES (pH 7.9), 50 mM KC1, 0.5 mM DTT, 5 mM MgCl 2 , and 10% glycerol. Samples were loaded onto 5% polyacrylamide gels (30:1 acrylamide:bisacrylamide) containing 2.5% glycerol and electrophoresed at 8 V/cm for 3.5 hr at room temperature with buffer recirculation in 12.5 mM Tris-Cl (pH 8.5), 95 mM glycine, and 0.5 mM EDTA. After electrophoresis, gels were fixed in 10% methanol, 10% acetic acid for 10 min, rinsed in water, vacuum dried, and exposed to Kodak XAR film.
RESULTS
Analysis of the E-box regions associated with the contractile protein gene enhancers Tnl (14) and MCK (19) , the cardiac aactin promoter (23) and an immunoglobulin x gene enhancer (44) revealed that although each contains a defined E-box consensus (CANNTG), the central and flanking nucleotides are not conserved (Figure 1 ). Based on a number of known functional E-boxes, Buskin and Hauschka (38) assigned a numerical value to each nucleotide within a fourteen base pair region surrounding the core E-box sequence and thereby proposed an E-box consensus that takes into account nucleotides flanking the four core positions. Each core nucleotide was assigned a value of 1.0 whereas matches with either of the degenerate flanking nucleotides were given a value of 0.5. The maximal match to the regional consensus is 8.0, which is the score attributed to the MCK right site (Figure 1 ). The Tnl and IgxE2 E-boxes contain single mismatches from the regional consensus, giving each a score of 7.5. The MCK left site and the cardiac a-actin E-boxes are more widely diverged with two (score of 7.0) and three (score of 6.5) mismatches, respectively. The relative strengths of these E-boxes within a specific regulatory element in promoting a transcriptional response have not been determined.
MyoD-induced expression of native E-box regulatory elements
Each E-box containing regulatory element is composed of a unique array of protein binding sites with which the bHLH proteins and other transcription factors interact, hi some cases, such as for the MCK and Igx enhancers, multiple E-box sites exist whereas single E-boxes are present within the Tnl and cardiac a-actin regulatory elements (Figure 2A) . Additionally, the E-box sequences are distinct within these regulatory elements suggesting that different combinations of bHLH proteins, especially in the case of the Igx enhancer, may interact with these sites in vivo. Thus, it is likely that within a given regulatory element, each E-box plays a slightly different role in the activation of gene expression. In order to compare directly how specific E-boxes function within their native regulatory elements, the enhancer regions associated with the Tnl, MCK, and Igx genes, and the promoter region associated with the cardiac a-actin gene, were ligated in a 3' -5' orientation to the Elb TATA-CAT reporter gene (34) which normally is inactive in 10T1/2 cells (14) . In addition to the wild-type regulatory regions, an MCK enhancer containing a mutated right E-box was examined for enhancer activity. The resulting mutant MCK enhancer contains the sequence CCAACACGGTAACC in place of the wild-type MCK right site E-box (38) . A similar mutation of the Tnl E-box consensus sequence also was generated for these studies (Figure 1 ). Co-transfection of 10T1/2 cells with each Elb TATA-CAT construct and with a MyoD expression vector allowed us to determine whether the different reporter gene constructs were activated to similar levels by the bHLH transcription factor MyoD.
The levels of expression of the Elb TATA-CAT reporter genes containing each of the regulatory elements was at or below the minimum level of CAT enzyme detection when co-transfected with the pEMSVscribea2 control plasmid into 10T1/2 cells. 10T1/2 cells co-transfected with the Tnl enhancer (IRE) reporter gene and the MyoD expression vector, however, exhibited ã 100-fold increase in CAT expression when compared to the pEMSVscribea2 control ( Figure 2B) . Mutation of the TG nucleotide pair of the Tnl E-box consensus, along with the adjacent flanking nucleotide eliminated >95% of the observed /ra/iv-activation obtained with the wild-type Tnl enhancer sequence. In contrast, the cardiac a-actin promoter element, when ligated in a 3'-5' orientation adjacent to the Elb TATA promoter, was rra/u-activated by MyoD to levels that were at least eight-fold higher than the /rans-activation levels detected with the wild-type Tnl enhancer ( Figure 2B ). Thus, while both Tnl and cardiac a-actin regulatory elements contain single Eboxes, the cardiac a-actin promoter is fra/u-activated more efficiently by MyoD than the Tnl enhancer element when placed adjacent to the Elb TATA-CAT reporter gene. Co-transfection of the wild-type MCK enhancer with MyoD also produced transactivation levels that were approximately 5-fold higher than the wild-type Tnl IRE. The strong levels of frans-activation attributed to the MCK enhancer were greatly reduced, however, when the MCK right E-box was mutated ( Figure 2B ). The right site has been described as the stronger of the two MCK E-boxes (19) and alteration of six nucleotkles, including the TG consensus nucleotides, reduced the MyoD frans-activation response of the MCK enhancer to < 5% of the original expression level, despite the presence of an intact MCK left E-box.
Although Igx gene expression in vivo is B-cell specific, Igx enhancer activity can be induced in certain cell types, such as yeast, in response to over-expression of the E2A bHLH protein gene products (45) . The Igx enhancer contains three binding sites for bHLH proteins, the strongest of which is the IgxE2 site ( Figure 2A ) since mutation of this site essentially eliminates enhancer function (44) . In addition to the three E-boxes, the Igx enhancer contains a binding site for NFxB which also is involved in B-cell specific expression (44) . As expected, the Igx enhancer is silent in 10T1/2 cells co-transfected with the control pEMSVscribea2 vector, demonstrating that the endogenous levels of E2A proteins in 10T1/2 cells are not sufficient for the activation of the Igx reporter gene. However, Elb TATA-CAT reporter genes containing the Igx enhancer were activated approximately 100-fold when co-transfected with a MyoD expression plasmid ( Figure 2B ). The level of expression from the Igx enhancer was similar to that of the muscle-specific Tnl enhancer, suggesting that in the presence of high levels of MyoD, the Igx enhancer is transcriptionally activated in converted muscle cells. These experiments demonstrate that the muscle-specific regulatory elements associated with the Tnl, MCK, and cardiac a-actin genes, along with the enhancer element associated with the Bcell specific Igx gene, are activated by bHLH proteins but are unique in how they respond to high levels of MyoD.
In order to directly compare muscle-specific gene activation, each E-box containing regulatory element also was introduced into the myogenk cell line 23A2 (40) . While 23A2 cells express MyoD, the levels of MyoD per cell are at least 20-fold lower in 23A2 myofibers than in MyoD-transfected 10T1/2 cells (35) . Transfection of the Tnl, MCK, and cardiac a-actin musclespecific regulatory elements into 23A2 myofibers produced relative levels of expression that were similar to the levels obtained in the MyoD co-transfections of 10T1/2 cells (Table  1) . For example, expression from the MCK enhancer and cardiac a-actin promoter (3'-5') was 3-4 fold higher than expression from the Tnl enhancer, whereas mutations in the consensus nucleotides of the Tnl E-box or mutations in the MCK right site essentially eliminated muscle-specific expression (Table 1) . Interestingly, the B-cell specific Igx gene enhancer was relatively inactive in 23A2 myofibers, suggesting that high levels of MyoD expression in 10T1/2 cells are required for its activation, whereas in 23A2 myofibers B-cell specificity is preserved. These studies indicate that regulatory elements containing different E-box sequences display unique levels of CAT expression in both MyoD co-transfections and in 23A2 myofibers. Additionally, the Igx enhancer is differentially active in the two experimental systems.
Transcriptiona] activity of Tnl enhancers containing specific E-box substitutions
In order to determine how individual E-box sequences affect the extent of gene activation, E-box substitutions were made in the Tnl enhancer. The Tnl enhancer was chosen for these studies because it contains a single E-box that must be linked to Sites I and n, which contain binding sites for ubiquitously expressed proteins ( Figure 3A ) (14) . The ability of different E-box sequences to potentiate Tnl enhancer activity was compared directly by replacing the E-box sequence of the Tnl IRE with E-box sequences from the cardiac a-actin promoter, the MCK right and left sites as well as with the IgxE2 site. Five to seven point mutations were introduced within the fourteen base pair Tnl E-box region in order to produce a sequence which was identical to the other E-box elements ( Figure 1 ). As discussed above, within their native regulatory elements, the different Eboxes are responsible for different levels of gene expression, and the additional proteins that also bind to these elements likely play different roles in transcriptional activation. Thus, by changing the E-box sequence but preserving the precise spacing of E-box nucleotides with respect to Site I and Site II of the Tnl enhancer, we were able to test whether the composition of nucleotides flanking the E-box consensus is important for gene activation. In addition, these studies facilitated a direct comparison of different E-boxes to determine whether specific sequences were more efficient than others in activating gene expression within a common genetic element.
To assess the relative abilities of E-boxes from different sources to function in Tnl gene activation, 10T1/2 cells were cotransfected with the MyoD expression vector and each mutant Tnl IRE linked to Elb TATA-CAT. None of the substituted IREs was expressed in 10T1/2 cells in the absence of MyoD, confirming that the bHLH proteins endogenous to 10T1/2 cells are not sufficient by themselves to activate any of the troponin I E-box substituted IREs, including the immunoglobulin xE2 Ebox IRE. As in the previous experiments, co-transfection of the wild-type Tnl IRE with MyoD resulted in Jra/u-activation -100 fold over the levels obtained in the pEMSVscribea2 control transfections. Surprisingly, the cardiac a-actin E-box, which is essential to the muscle-specific activation of the cardiac a-actin promoter (23) , is not functional when placed within the context of the Tnl enhancer element (Figure 3B) , even though the aactin promoter linked to the Elb reporter gene is activated approximately 8-fold higher than the Tnl enhancer ( Figure 2B ). The Tnl IRE substituted with the cardiac a-actin E-box produced levels of expression comparable to the Tnl mutant E-box consensus sequence which, as discussed previously, is not efficiently frans-activated by MyoD. These results suggest that substitution of the Tnl E-box flanking nucleotides with the same nucleotides present within the a-actin E-box renders the IRE nonfunctional. Unlike the cardiac a-actin E-box, however, the relative strengths of the two MCK E-boxes were conserved when positioned within the Tnl IRE. Substitution of the MCK right E-box site resulted in levels of tra/is-activation similar to the wildtype IRE (>90%), while substitution of the MCK left E-box site produced levels of fra/is-activation that were -75% lower than the wild-type Tnl or MCK right site IREs ( Figure 3B ). Thus the MCK right E-box remains the stronger of the two sites within the Tnl IRE as well as within the MCK upstream enhancer.
Unlike the MCK right site, which can substitute efficiently for the Tnl E-box, the IgxE2 E-box is not functionally equivalent to the Tnl E-box. Although both the IgxE2 and Tnl sites contain only single mismatches of the E-box consensus sequence, replacement of the Tnl E-box with the IgxE2 sequence led to a -60% decrease in gene activity ( Figure 3B ). Thus the nucleotide changes in the IgxE2-IRE, unlike the MCKR-IRE, are non-conservative substitutions. While the IgxE2 element is integral to the function of the Igx enhancer (44), it can not substitute efficiently for the E-box in the Tnl IRE. However, the IgxE2 site is stronger than the MCK left site or the cardiac aactin site when these are placed within the context of the Tnl enhancer, suggesting that the IgxE2 site itself can function in the context of a muscle-specific element. Similar relative levels of fra/is-activation also were observed when a myogenin expression vector was co-transfected into 10T1/2 cells with each reporter gene construct (data not shown). Thus each IRE E-box substitution produces a unique level of fra/is-activation by MyoD, suggesting that E-box sequences outside the CANNTG core consensus play an important role in determining the extent of gene activation in vivo.
The ability of the E-box substituted Tnl IRE constructs to support enhancer activity also was tested in the myogenic cell line 23A2. As shown in Table 1 , introduction of each mutant into 23A2 myofibers produced similar relative levels of gene activation as obtained by co-transfecting 10T1/2 cells with MyoD. For example, the MCK right site was functionally equivalent to the native Tnl E-box sequence within the IRE. However, the presence of the cardiac a-actin E-box produced levels of expression comparable to the low levels obtained with the mutant Tnl IRE (muTnl). Similarly, the MCK left site E-box also supported very low levels of gene activation when placed within the context of the Tnl enhancer. Interestingly, substitution of the IgxE2 site into the Tnl IRE produced moderate levels of musclespecific gene activity as was observed for MyoD co-transfections, even though reporter genes containing the complete Igx enhancer are not efficiently expressed in differentiated myofibers (Table  1) . Thus, within the context of the muscle-specific Tnl enhancer, unlike within its native enhancer, the IgxE2 E-box is similarly effective in 23A2 myofibers and in 10T1/2 MyoD cotransfections. The ability of different E-boxes to function within the IRE enhancer element suggests that some flexibility in the sequences within and flanking the E-box core consensus exists. However, within this context, not all changes are equally recognized since some substitutions, especially those that produce the cardiac a-actin E-box, can greatly inhibit the activation of gene expression by the muscle regulatory factors.
Tnl E-box substitutions exhibit variable binding of MyoD:E12 complexes
Although previous studies have shown that the muscle regulatory factors efficiently bind to various E-box sequences, we next examined whether the inability of some E-boxes to support transcription when positioned within the Tnl IRE was due to an inability to generate stable protein:DNA complexes. To examine this possibility, binding of MyoD:E12 hetero-dimers to each Ebox sequence within the context of the Tnl IRE was assessed by gel mobility shift assays. MyoD:E12 proteins generated from mRNA transcribed and translated in vitro were incubated with radiolabelled mutant IREs and subjected to native gel polyacrylamide electrophoresis. As expected, no binding was detected when various IREs were incubated with MyoD or with E12 alone (data not shown, 14). However, MyoD:E12 protein complexes readily bound to the native Tnl IRE while mutation of the E-box consensus nucleotides completely eliminated MyoD:E12 binding (Figure 4) . Very strong binding of MyoD:E12 complexes to the IRE containing the MCK right site (MCKR) also was observed. Thus, the wild-type Tnl and MCK right E-boxes, which support the highest levels of ma/is-activation when placed within the Tnl IRE, also exhibit efficient binding of MyoD:E 12 complexes in vitro. The -60% lower levels of /ro/is-activation obtained with the Igx substituted IRE also was reflected in a lower intensity of MyoD:E12 binding to the Igx E-box contained within the Tnl IRE. In contrast, the MCK left site, which when substituted into the Tnl IRE supported only very low levels of gene expression in MyoD transfected 10T1/2 cells, inefficiently interacted with MyoD:E12 complexes since binding activity in these assays was apparent only with prolonged exposures of the autoradiograph. No MyoD:E12 binding was detected for the cardiac a-actin E-box IRE which contains an intact E-box consensus but was fra/u-activated to the same low background levels as observed with the Tnl IRE mutant E-box consensus. Thus the binding activities of the mutant IREs in vitro correlate with their ability to support fra/is-activation by MyoD in vivo, suggesting that the nucleotide substitutions that were generated within the Tnl IRE E-box significantly affect how the muscle regulatory factors interact with each regulatory element.
DISCUSSION
In these studies we have demonstrated that E-boxes consisting of different nucleotide sequences and derived from different genetic origins display distinct activities when placed within the context of a single regulatory element. Although each tested Ebox is functional within its native gene, the response to overexpression of the bHLH protein MyoD was distinct for each sequence. Since each of the E-boxes contain the CANNTG core consensus, the differences in their f/ms-activation potentials when placed within the IRE demonstrate the importance of the flanking and internal nucleotides in determining E-box function. In addition, the ability of the E-box binding proteins to interact with other proteins that are essential to Tnl gene activation also may be affected by specific E-box sequences. Thus the multiple protein:DNA interactions involved in activating E-box containing regulatory elements may require different binding properties and therefore different E-box target sites for the activation of specific genes.
The ability of some E-boxes to function more efficiently than others within the context of the Tnl enhancer suggests that the nucleotide changes represent both conservative and nonconservative substitutions. For example, the five nucleotide changes that are represented in the MCK right E-box are comparable in activity to the native Tnl E-box in supporting muscle gene activation. However, the six different nucleotide changes that are represented in the IgxE2 site produced a 60% reduction in enhancer activity. Interestingly, the Tnl and Igx Eboxes are equally diverged from the consensus sequence based on E-box nucleotide similarities (see Figure 1) , suggesting that the degree of similarity to the consensus E-box sequence may not be fully indicative of enhancer function. However the MCK left site, which diverges from the consensus more than the Igx E-box, produced a 70% reduction in Tnl gene activity, while the cardiac a-actin E-box, which contains the least homology to the E-box consensus, displayed only background expression levels. Thus there may be a correlation between divergence from the consensus sequence at this level and the strength of the Ebox sequence when placed within the context of the Tnl enhancer.
Perhaps the most striking difference between E-box sequences that function within the Tnl enhancer and those that do not is the presence of two G/C base pairs found between the consensus nucleotides of the Tnl, MCKR, and IgxE2 sites and the presence of a single A/T base pair in the weaker MCKL and cardiac aactin E-boxes. DNA binding studies have indicated that the base pairs internal to the consensus are important contact points for MyoD:E12 interactions (13) (14) (15) . In addition, substitution of the two internal G/C base pairs of the IgH/tE5 E-box with two A/T base pairs strongly inhibits binding and activity of the /iE5 site (45) . Consensus sequences established by CASTing and SAABing techniques also have revealed a preference for internal G/C base pairs within the consensus nucleotides (28, 29) . However, the presence of two G/C nucleotides is not sufficient to achieve complete activity since the IgxE2 site, when positioned within the Tnl enhancer, resulted in a decrease in activity despite the presence of CAGGTG. A comparison of the E-boxes tested in this study also has revealed a second short palindromic sequence that shares the G nucleotide of the CANNTG palindrome (see Figure 1 ). In the Tnl and MCKR sites the sequence is GCNGC and in the IgxE2 site the sequence is GGNCC. The MCKL and cardiac a-actin E-boxes, which display the lowest levels of activity within the Tnl enhancer, do not contain a second palindromic sequence. These adjacent sequences could serve to stabilize protein binding to the E-box although the significance of these sequences has yet to be determined. In addition, we have been unable to detect a correlation between the predicted melting temperatures of the fourteen base pair E-box regions and their ability to function within me Tnl enhancer.
Protein: DNA binding studies presented here and elsewhere suggest that the MyoD:E12 hetero-dimers bind with different affinities to different E-box sequences. For example, within the MCK enhancer it has been shown that MyoD and myogenin bind more readily to the right E-box site than to the left site (13, 19) . Different binding affinities also have been observed for the different E-boxes within the myosin light chain 1/3 enhancer and the immunoglobulin n enhancer (15, 18) . In addition, we have shown that within the same regulatory element, different E-boxes have distinct binding affinities for MyoD. These studies demonstrate that despite the presence of the E-box consensus sequence in each of these binding sites, the adjacent nucleotides affect how the bHLH proteins interact with these sequences within the Tnl enhancer and their ability to bind directly corresponds to the level of fra/ty-activation obtained with each substituted IRE. However the binding studies in vitro do not take into account the interactions of additional proteins bound to individual regulatory elements that could also affect the stability of these interactions in vivo. For example, the apparent inability of MyoD to bind or fra/ts-activate the cardiac a-actin E-box when placed within the Tnl enhancer may not reflect how MyoD interacts with the native cardiac a-actin promoter in vivo, since within this context the E-box is necessary for the muscle-specific activation of cardiac a-actin gene expression (23) . Thus the differential fra/iy-activation of Tnl enhancers containing specific E-boxes may reflect the ability of MyoD to activate genes containing different E-box sequences as well as the ability of MyoD to interact with other transcription factors bound to the same regulatory element in muscle cells (14) .
The interactions of bHLH proteins with different E-box sequences have been shown to be important for the regulation of a wide variety of genes including the contractile protein (reviewed in 8), immunoglobulin (44) , pancreatic (46) , and SV40 (47) genes. The diversity of E-box proteins and of E-box sequences suggests that the different patterns of gene expression from these diverse genes could be established at least in part by specific E-box nucleotides. In addition, for many of these genes other proteins that bind to adjacent sequences also are required for their complete activation. Thus the specificity between bHLH proteins and their target sequences may have evolved to optimize these interactions. The studies presented here support this hypothesis since within the context of the same regulatory element, E-boxes from different sources are not equivalent.
